VEGF Inhibitor Drugs Market Analysis

The vascular endothelial growth factor inhibitors market is segmented by target, by inhibitor, by application, by distribution channel and region, out of which, the target segment is further segmented into VEGF-A, VEGF-B, VEGF-C, VEGF-D and others. The market for VEGF-A is anticipated to hold the largest share in the market on account of VEGF-A being responsible for inducing angiogenesis as well as regulating the cell division in endothelial cells.

On the basis of application, the vascular endothelial growth factor inhibitors market is segmented into oncology, ophthalmology and others, out of which, the segment for oncology is predicted to grow at the highest rate over the forecast period. This can be attributed to the rising cases of cancer globally, along with the increasing demand for effective cancer therapies which result in minimum side effects. The Centers for Disease Control and Prevention estimated the number of new cancer cases to increase by around 24% among men between 2010 and 2020 and by about 21% among women during the same period in the United States.

Our in-depth analysis of the global market includes the following segments: